LAPTM4B and neoplasm: The oncogene lysosome-associated protein transmembrane-4β (LAPTM4B) was first cloned in hepatocellular carcinoma (HCC) [9], and the polymorphism region in the 5′-UTR of the gene is associated with tumor susceptibility [10–19].